UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Naproxen release aspect from boron-doped carbon nanodots as a bifunctional agent in cancer therapy

RSC advances, 2021-11, Vol.11 (59), p.37375-37382

2021

Volltextzugriff (PDF)

Heterogeneous base catalysts for edible palm and non-edible Jatropha-based biodiesel production

BMC chemistry, 2014-05, Vol.8

2014

Volltextzugriff (PDF)

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1360-1372

2017

Volltextzugriff (PDF)

Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone

Substance use & misuse, 2022, Vol.57 (11), p.1732-1742

2022

Volltextzugriff (PDF)

Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone

Drug and alcohol dependence, 2022-07, Vol.236, p.109469-109469, Article 109469

2022

Volltextzugriff (PDF)

Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

American journal of human genetics, 2013-04, Vol.92 (4), p.489-503

2013

Volltextzugriff (PDF)

Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana

Human vaccines & immunotherapeutics, 2017-02, Vol.13 (2), p.306-313

2017

Volltextzugriff (PDF)

Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder

Journal of addiction medicine, 2023-09, Vol.17 (5), p.618

2023

Volltextzugriff (PDF)

Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia

Brain (London, England : 1878), 2021-06, Vol.144 (5), p.1422-1434

2021

Volltextzugriff (PDF)

Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities

Journal of medicinal chemistry, 2006-05, Vol.49 (9), p.2703-2712

2006

Volltextzugriff (PDF)

Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse

Journal of substance abuse treatment, 2021-12, Vol.131, p.108447-108447, Article 108447

2021

Volltextzugriff (PDF)

Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure

Journal of substance abuse treatment, 2021-05, Vol.124, p.108292-108292, Article 108292

2021

Volltextzugriff (PDF)

Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse” [Journal of Substance Abuse Treatment 131 (2021) 108447]

Journal of substance abuse treatment, 2022-05, Vol.136, p.108566-108566, Article 108566

2022

Volltextzugriff (PDF)

Ferredoxin from sweet pepper (Capsicum annuum L.) intensifying harpin(pss)-mediated hypersensitive response shows an enhanced production of active oxygen species (AOS)

Plant molecular biology, 2003-04, Vol.51 (6), p.913

2003

Volltextzugriff (PDF)

Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities

Journal of medicinal chemistry, 2006-05, Vol.49 (9), p.2703-2712

2006

Volltextzugriff (PDF)

Thermal-Induced Chemical Modification of Palladium Acetate on the Submicrometer Scale by in Situ Scanning Thermal Microscopy

Langmuir, 1999-03, Vol.15 (7), p.2425-2430

1999

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Naproxen release aspect from boron-doped carbon nanodots as a bifunctional agent in cancer therapy

Heterogeneous base catalysts for edible palm and non-edible Jatropha-based biodiesel production

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone

Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone

Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana

Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder

Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia

Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities

Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse

Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure

Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse” [Journal of Substance Abuse Treatment 131 (2021) 108447]

Ferredoxin from sweet pepper (Capsicum annuum L.) intensifying harpin(pss)-mediated hypersensitive response shows an enhanced production of active oxygen species (AOS)

Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities

Thermal-Induced Chemical Modification of Palladium Acetate on the Submicrometer Scale by in Situ Scanning Thermal Microscopy

Suchergebnisse filtern